Chemotherapy for malignant gliomas.
Forsyth
P A
PA
Department of Clinical Neurological Sciences, University of Western Ontario, Calgary, Alberta, Canada.
Cairncross
J G
JG
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D005910:Glioma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use*; D015996:Survival Rate
D000970:Antineoplastic Agents; D011344:Procarbazine; D008775:Methylprednisolone